SINOVAC BIOTECH LTD Quarterly Retained Earnings (Accumulated Deficit) in USD from Q4 2010 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
The cumulative amount of the reporting entity's undistributed earnings or deficit.
Summary
Sinovac Biotech Ltd quarterly Retained Earnings (Accumulated Deficit) history and growth rate from Q4 2010 to Q4 2023.
  • Sinovac Biotech Ltd Retained Earnings (Accumulated Deficit) for the quarter ending December 31, 2023 was $7.12B, a 1.49% decline year-over-year.
Retained Earnings (Accumulated Deficit), Quarterly (USD)
Retained Earnings (Accumulated Deficit), YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $7.12B -$107M -1.49% Dec 31, 2023 20-F 2024-04-29
Q4 2022 $7.23B +$84.2M +1.18% Dec 31, 2022 20-F 2024-04-29
Q4 2021 $7.14B +$7B +4851% Dec 31, 2021 20-F 2023-05-01
Q4 2020 $144M +$87.5M +154% Dec 31, 2020 20-F 2022-04-29
Q4 2019 $56.7M +$32.9M +138% Dec 31, 2019 20-F 2021-04-22
Q4 2018 $23.8M +$14.7M +161% Dec 31, 2018 20-F 2020-04-30
Q4 2017 $9.13M +$21M Dec 31, 2017 20-F 2019-04-29
Q4 2016 -$11.9M -$1.93M -19.4% Dec 31, 2016 20-F 2018-05-11
Q4 2015 -$9.98M -$3.6M -56.3% Dec 31, 2015 20-F 2017-11-22
Q4 2014 -$6.38M Dec 31, 2014 20-F 2016-04-25
Q4 2011 $2.7M -$1.18M -30.4% Dec 31, 2011 20-F 2012-04-12
Q4 2010 $3.88M Dec 31, 2010 20-F 2012-04-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.